ENCR Call for Data 21 May 2010

Similar documents
A Comprehensive Approach to. International Cancer Survival Benchmarking. SurvMark-2

ENCR-JRC Call for Data, 2015

THE PROCESS OF CANCER REGISTRY DATA QUALITY EVALUATION

Cancer in Estonia 2014

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report

Integration of hospital based breast cancer data and population based data at the Greater Poland Cancer Centre

Cancer Incidence in Five Continents. Volume VIII

Cancer in the Arabian Gulf Kingdom of Bahrain ( ) Fayek A Alhilli, PhD (Path)* Nagalla S Das, MD*

Downloaded from:

Planning a Community based Cancer Registry. Cancer Registration: Principles and Methods Edited by Jensen O. M. et al IARC 1991; pages

14. Cancer of the Cervix Uteri

This section allows identifying the facility, this information is important for data quality follow up. Source of Standard. Source of Standard

AJCC TNM 6 th Edition Staging Input Data Dictionary

Cancer survival in Chennai (Madras), India,

CODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser

EUROCHIP-II FINAL SCIENTIFIC REPORT ANNEX 08 REPORT OF ESTONIA

Cancer Incidence and Mortality: District Cancer Registry, Trivandrum, South India

Cancer survival in Hong Kong SAR, China,

Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database

Cancer survival in Bhopal, India,

Global surveillance of cancer survival

Cancer survival in Khon Kaen, Thailand,

Cancer survival in Harare, Zimbabwe,

Lung Cancer and Mesothelioma Site Specific Clinical Reference Group Data Quality Report 2009

Cancer survival in Seoul, Republic of Korea,

Volume 10 Cervix Cancer Screening

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Opportunities for Cancer Control An overview of screen-detectable and tobacco-related cancer in New Mexico

ANCR. PC-NORDCAN version 2.4

General. Identification. Loire-Atlantique/Vendée cancer registry (registre. Detailed name. qualifié)

Annual report on status of cancer in China, 2011

Analyses on Cancer Incidence and Mortality in Huai an Area, China, 2010

Attending Physician Statement- Cancer or Carcinoma in-situ

Summary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance

Cancer survival in Busan, Republic of Korea,

Rare Urological Cancers Urological Cancers SSCRG

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

Cancer in Ireland : Annual Report of the National Cancer Registry

Annual Report with statistical data from Bermuda National Tumour Registry. Bermuda Hospitals Board Office of the Chief of Staff, KEMH

Appendix 4. Automation in cancer registration

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Report on Cancer Statistics in Alberta. Melanoma of the Skin

Enrollment Form: Pancreas

Breast Cancer Staging

Annual report on status of cancer in China, 2010

Cancer registry. Azin.Nahvijou, MD, PhD Candidate

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

Cancer as a Disease. Linda D. Rego, CTR March 2009

TARGETS To reduce the age-standardised mortality rate from cervical cancer in all New Zealand women to 3.5 per or less by the year 2005.

INTRODUCTION TO CANCER STAGING

FCDS TENTATIVE V11 TO V11.1 IMPLEMENTATION SCHEDULE

Reporting of Cancer Stage Information by Acute Care Hospitals in Ontario

Aviva Group Protection Our guide to cancer

Prediction of Cancer Incidence and Mortality in Korea, 2018

THE ISSUE OF STAGE AT DIAGNOSIS

Waiting Times for Suspected and Diagnosed Cancer Patients

Report on Cancer Statistics in Alberta. Breast Cancer

Report on Cancer Statistics in Alberta. Childhood Cancer

Report on Cancer Statistics in Alberta. Kidney Cancer

National Cervical Screening Programme. Annual Report 2014

CODING PRIMARY SITE. Nadya Dimitrova

General French Cancer Registries The example of the Cancer Registry of Doubs and Belfort Territory

BreastScreen Aotearoa Annual Report 2015

United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2017 report Published XX June 2017

Common Questions about Cancer

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Methodology for the Survival Estimates

Ovarian Cancer Prevalence:

ALL CANCER (EXCLUDING NMSC)

Cancer in the Northern Territory :

Audit. Public Health Monitoring Report on 2006 Data. National Breast & Ovarian Cancer Centre and Royal Australasian College of Surgeons.

Measuring the value of healthcare activities. Susan Rollason, Director of Finance and Strategy

WHI Extension Appendix A, Form Report of Cancer Outcome (Ver. 8.2) Page 1

We re on the Web! Visit us at VOLUME 19 ISSUE 1. January 2015

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Methods and Limitations Overview

Cancer in Ireland : Annual Report of the National Cancer Registry

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database

ALL CANCER (EXCLUDING NMSC)

Nationwide Cancer Incidence in Korea,

LYMPHATIC DRAINAGE IN THE HEAD & NECK

Combined chemotherapy and Radiotherapy for Patients with Breast Cancer and Extensive Nodal Involvement.

Cancer Incidences in Rural Delhi

COSD & Source of Referral

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Cancer in Ireland with estimates for

Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD,

NHS. Northern and Yorkshire Cancer Registry and Information Service

Carcinoma of the Urinary Bladder Histopathology

2010 Cancer Data Collection Updates: Standards Volume II, Introduction. What s New for 2010

Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)

Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period

Cancer Profile in Patan District, Gujarat: A Comprehensive Review

Chapter 13 Cancer of the Female Breast

Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer

Transcription:

E N C R EUROPEAN NETWORK OF CANCER REGISTRIES ENCR Secretariat International Agency for Research on Cancer 150 cours Albert Thomas 69372 Lyon Cedex 08 - France Tel.: +33 (0)472 73 84 66 Fax: +33 (0)472 73 86 96 htpp://www.encr.com.fr ENCR Call for Data 21 May 2010 EUROCOURSE: data harmonisation, analysis and exchange... 2 Annex 1. Submission instructions... 3 Annex 2. Required data files... 4 1. Cancer cases file... 4 2. Population data file... 8 3. Mortality data file... 9 4. Population life tables...10 Annex 3. References...11 Annex 4. ENCR data call requirements at a glance...12

EUROCOURSE: data harmonisation, analysis and exchange EUROCOURSE aims to strengthen the basis for monitoring cancer incidence and mortality in Europe through the provision of regular and timely information from European cancer registries, obtained via a single quality-assured gateway. The registries are equal partners in the project through their participation in the various working groups carrying out particular tasks or activities, as well as through the ENCR Steering Committee. Work Packages 3 and 4 are concerned with improving the quality, coverage and use of cancer registration data in Europe (WP3) and the development, harmonisation, analysis and exchange of European cancer registry (WP4). Working Groups have been convened by the respective WP leaders, Roberto Zanetti (roberto.zanetti@cpo.it) and Harry Comber (h.comber@ncri.ie), to ensure, on behalf of the registries, appropriate strategies for the quality assurance, analysis and online dissemination of the datasets received. The recommendations of a Working Group chaired by Henrik Møller (henrik.moller@kcl.ac.uk) provided the basis for this call, and two further Working Groups will advise on 1) the analysis and presentation of key statistics on the cancer burden in Europe (chaired by Freddie Bray, Brayf@iarc.fr) and 2) the sharing of data and its ownership (chaired by Stefano Rosso, stefano.rosso@cpo.it). It is envisaged that three levels of EUROCOURSE output will be considered by these working groups in close consultation with the Registries, the ENCR Steering Committee and its Secretariat at IARC: EUCAN 2010 An online analysis tool for investigating the geographical patterns of cancer incidence and mortality according to the major sites of cancer. National estimates for 2010 will be derived for the 40 countries of greater-europe. EUROCAN Using NORDCAN (http://ancr.nu) as a model, EUROCAN will provide tabular and graphical analyses of country-specific patterns and trends on the basis of national registry data or via an aggregation of regional data. The inclusion of sub-national data (from individual regional registries) will be explored by the above parties. EUROCIM-2 A new version of EUROCIM comprising of databases of registry-specific incidence and mortality data available at different levels of topographical / morphological detail (ICD-10, histology-specific entities etc.). Initially delivered to all registries who submit their data to the gateway, issues of ownership, provision of analytic tools etc. will be explored by the above parties. 2

Annex 1. Submission instructions Files preparation The cancer cases file should be zipped and protected by a password before submitting. There are no specific requirements for the names of the files. It is preferable NOT to zip together the other files (population, coding, etc.), so as to allow automating sorting of files and renaming them to a standard filenames on submission. The following files should be submitted: 1. Cancer cases file 2. Population file 3. Life-table file (if follow-up information is available in the Cancer cases file) 4. Mortality file 5. A file specifying any non-standard coding variables CIN portal at IARC Submission of the files through the new CIN portal is strongly recommended. Using the portal will allow you benefit from the following features: High security and speed of data transfer No packaging No need for accompanying correspondence On-line confirmation of participation Automated data submission and its acknowledgement On-line monitoring of the progress of data processing at IARC One submission for several projects Instructions are provided on the portal for each step required for the file upload. Specific help is available on request. During the submission on the portal it will be possible to specify the call each data file is submitted for. If a registry wishes to submit different data items or different coding for different studies, a separate submission of relevant files is recommended for each study. The CIN portal is located at the following address: http://cinportal.iarc.fr/. To enter the portal, the registry-specific username and password are required. They were communicated to each registry individually. Contact and other submission paths It is possible to submit the files on a CD or by e-mail to the address shown below, although the submission through the new portal is preferable: ENCR Secretariat 150 cours Albert Thomas 69372 Lyon Cedex 08 FRANCE encr@iarc.fr Deadline for inclusion in the first database release: 30 June 2010 3

Annex 2. Required data files The list below shows the requirements of the content and format of the files to be submitted, separately for each file type. 1. Cancer cases file Inclusion criteria Period All available registration years considered complete The latest available closing date of follow-up for vital status Tumour All primary tumours, including, if collected: Basal cell and squamous cell carcinomas of skin Non-malignant tumours of CNS Non-malignant tumours of the urinary bladder in situ tumours of breast, cervix, colon, rectum and melanoma of the skin Age All ages eligible for registration In the age-restricted cancer registries, all subsequent primary tumours of the registered patients should be included irrespectively of age at diagnosis, where available Requested quality and coding Data should be verified and corrected before the submission using, for example, IARCtools or DEPedits. Duplicate registrations should be removed. All multiple primary tumours should be retained in the file. The coding schemes outlined in detail in Table 1, Example 1 and Example 2 should be used. In particular, ICD-O-3 coding system is requested for all relevant variables. IARCtools software could be used to convert coding of other systems. Requested format In general, the files should be formatted as follows: One record per line Delimited field format Predefined format and record layout outlined below Mandatory variables must be completed for all records Optional variables be completed for all records, if collected Data for each registry (distinguished by its registry code) should be recorded in a separate file. Requested accompanying information Coding scheme for all variables using other than recommended coding (See Table 1) 4

Table 1. Cancer cases file: record layout and recommended coding (F=Numeric, A=Alphanumeric) Variable Format Recommended coding of values Regular Missing or Unknown Definition, notes 1. Patient identification number A20 Not allowed A unique identifier of the patient in the originating registry, which is not necessarily the official personal identification number. 2. Tumour sequence number F2 00=single tumour 01=1 st of more 02=2 nd of more 03=3 rd of more Etc. 99 A sequential number of all primary tumours diagnosed over the lifetime of a person in chronological order and included in the dataset. 3. Total number of tumours F2 Number 99 A count of all tumours diagnosed in one registered patient during the registry s activity. 4. Date of birth F8 DDMMYYYY 99999999 If date of birth cannot be provided in full, the next possible/available detail should be included, such as MMYYYY or DDYYYY 9 5. Sex at birth F1 1=Male 2=Female 6. Date of incidence F8 DDMMYYYY 9999YYYY See ENCR recommendations: Date of incidence 7. Date of registration F8 DDMMYYYY 99999999 Date when case first recorded in the registry database 8. Age in years F3 999 Latest completed year of age at the time of diagnosis 9. ICDO-3 Topography A4 ICD-O-3 Not allowed Example: C531 10. ICDO-3 Morphology F4 ICD-O-3 Not allowed Example: 8170 11. ICD-O-3 Behaviour F1 ICD-O-3 Not allowed Example: 3 12. Basis of diagnosis F1 ICD-O-3 See also ENCR recommendations for coding basis of diagnosis 0=DCO 1=Clinical 9 Minimum coding requirements 13. Detection of non-symptomatic cancer in an organised population-based screening programme F1 2=Microscopic 1=Screen detected 2=Other 9 See ENCR recommendations: Method of detection in relation to screening. An organised screening programme is defined as 'men and/or women in an identified population, invited to participate in a screening programme'. Mandatory variable 5

Variable Recommended coding of values Definition, notes Regular Missing or Unknown 14. Incidental finding of cancer at F1 1=Yes 9 the autopsy 2=No 15. Grade (ICDO-3) F1 ICD-O-3 9 Arabic numerals should be used for all codes 16. Laterality of paired organ F1 1=Unilateral 2=Bilateral 3=Right 4=Left 17. Vital status at last contact F1 1=Alive 2=Dead Format 9 A bilateral tumour to be recorded in a single record 9 Coding of Lost to follow-up should be as follows: Vital status should be set to 1 (alive) and Date of end of follow-up to the latest date when the patient was confirmed alive. 18. Date of end of follow-up F8 DDMMYYYY 99999999 Equivalent to Date of death for deceased patients and to Date of last contact for those alive at the end of follow-up. 19. Age at end of follow-up F3 Number 999 Integer part of the age reached at the date quoted in 18. Must be provided if any of 4, 6 or 18 is incomplete. 20. Duration of survival F5 Number of days 99999 Days between 6. Date of incidence and 18. Date of end of followup. Must be provided if either 6 or 18 are incomplete. 21. Cause of Death A4 ICD 9999 Code of the underlying cause of death 22. ICD edition F2 06=ICD-6 07=ICD-7 08=ICD-8 09=ICD-9 10=ICD-10 99, Not allowed for records with 21 provided Coding system used for the underlying cause of death 23. TNM stage, primary site A4 AJCC/UICC 9999 Examples: TX, pt0, Tis, T1a, T2, pt3, T4 24. TNM stage, lymph nodes A5 AJCC/UICC 99999 Examples: pnx, N0, pn1sn, N2b, N3 25. TNM stage, metastases A4 AJCC/UICC 9999 Examples: M0, M1 26. TNM stage grouping A2 AJCC/UICC 99 Arabic numerals should be used 27. TNM reference A3 U06=UICC 6 th Edition U07=UICC 7 th Edition 28. Condensed TNM, T A2 T1=Localised T2=Advanced 29. Condensed TNM, N A2 N1=No reg. nodes N2=Regional nodes 30. Condensed TNM, M A2 M1=No dist. metast. M2=Distant metast. 999 TX NX MX See ENCR recommendations: condensed TNM See ENCR recommendations: condensed TNM See ENCR recommendations: condensed TNM 6

Variable Recommended coding of values Definition, notes Regular Missing or Unknown 31. Extent of disease F1 1=Confined 9 See EUROCARE 5 protocol 2=Adjacent tissues 3=Distant organs 4=2 or 3 NOS 5=1 or 2 NOS 32. Tumour size in mm F3 Millimetres 999 33. Examined nodes F2 Number 99 Number of nodes examined 34. Metastatic nodes F2 Number 99 Number of nodes with the sign of malignant spread 35. C factor F1 1=C1, standard dg. See ENCR recommendations: condensed TNM 2=C2, special dg. 36. Surgery F1 1=yes 9 Non-investigative surgery within 6 months of diagnosis 37. Systemic therapy F1 1=yes 9 Systemic therapy (e.g. chemotherapy) within 6 months of diagnosis, including adjuvant systemic therapy 38. Radiotherapy F1 1=yes 9 Radiotherapy within 6 months of diagnosis, including adjuvant radiotherapy 39. Hormone therapy F1 1=yes 9 Hormone therapy within 6 months of diagnosis, including adjuvant hormonal therapy 40. Curative intent: surgery with F1 1=yes 9 EUROCARE-5 protocol curative intent 41. Curative intent: chemotherapy, F1 1=yes 9 EUROCARE-5 protocol including adjuvant 42. Curative intent: radiotherapy F1 1=yes 9 EUROCARE-5 protocol 43. Curative intent: other therapy F1 1=yes 9 EUROCARE-5 protocol 44. Symptomatic treatment F1 1=yes 9 EUROCARE-5 protocol 45. IARC flag F1 1=OK 9 Indicator of successful pass through IARC checks and conversions 2=OK after verification 0=failed Format 7

2. Population data file Scope The population data should correspond to the cancer cases file with respect to: registration area time period age-range If possible, population figures should give the mid-year estimates for each sub-category. File format Ideally, the file should contain a population figure for every combination of: Calendar year Sex Age (year unit if possible, standard 18 age-groups otherwise) Each line of the population file should include number of residents for the combination of calendar year, sex and age, as shown below (Example 1). Alternatively, the next finest level of detail available should be provided (Example 2). Data for each registry (distinguished by its registry code) should be recorded in a separate file or worksheet. The codes for sex should be the same as in the cancer cases file. Example 1: Example 2: Year Sex Age unit Number of residents Year Sex Age group Number of residents 1991 1 0 N 1,1,0 1991 1 1 N 1,1,1 1991 1 1 N 1,1,1 1991 1 2 N 1,1,2 1991 1 2 N 1,1,2 1991 1 3 N 1,1,3 1991 1 1991 1 1991 1 100 N 1,1,100 1991 1 18 N 1,1,18 1991 2 0 N 1,2,0 1991 2 1 N 1,2,1 1991 2 1 N 1,2,1 1991 2 2 N 1,2,2 1991 2 1991 2 1991 2 100 N 1,2,100 1991 2 18 N 1,2,18 1992 1 0 N 2,1,0 1992 1 1 N 2,1,1 1992 1 1992 1 1992 1 100 N 2,1,100 1992 1 18 N 2,1,18 1992 2 0 N 2,2,0 1992 2 1 N 2,2,1 2008 2 100 N 18,2,100 2008 2 18 N 18,2,18 Accompanying information required Any other than recommended coding should be documented. Reference to the source of population data should be provided. 8

3. Mortality data file It is not required to submit national mortality statistics, which may be retrieved directly from the WHO database. Scope The mortality data for the sub-national regions covered by a cancer registry should include all past residents whose underlying cause of death was cancer. The mortality data should correspond to the cancer cases file with respect to: registration area time period age-range File format Ideally, the file should contain the number of deaths for every combination of: Calendar year Sex Age (year unit if possible, standard 18 age-groups otherwise) Cause of death (3 characters of ICD code) Each line of the mortality file should include number of deaths for the combination of calendar year, sex, age and cause of death, as shown below (Example 3). Alternatively, the next finest level of detail available should be provided (Example 4). Data for each region (corresponding to the registration areas distinguished by separate registry codes) should be recorded in a separate file or worksheet. The codes for sex should be the same as in the cancer cases file. Year Example 3: Example 4: Age Cause of Age Sex Deaths Year Sex unit death group Cause of death Deaths 1991 1 0 C00 D 1,1,0,C00 1991 1 1 140 D 1,1,1,140 1991 1 1 C00 D 1,1,1,C00 1991 1 2 140 D 1,1,2,140 1991 1 2 C00 D 1,1,2,C00 1991 1 3 140 D 1,1,3,140 1991 1 1991 1 1991 1 100 C00 D 1,1,100,C00 1991 1 18 140 D 1,1,18,140 1991 2 0 C00 D 1,2,0,C00 1991 2 1 140 D 1,2,1,140 1991 2 1 C00 D 1,2,1,C00 1991 2 2 140 D 1,2,2,140 1991 2 1991 2 1991 2 100 C00 D 1,2,100,C00 1991 2 18 140 D 1,2,18,140 1992 1 0 C01 D 2,1,0,C01 1992 1 1 141 D 2,1,1,141 1992 1 1992 1 1992 1 100 C01 D 2,1,100,C01 1992 1 18 141 D 2,1,18,141 1992 2 0 C01 D 2,2,0,C01 1992 2 1 141 D 2,2,1,141 2008 2 100 C97 D 18,2,100,C97 2008 2 18 208 D 18,2,18, 208 Accompanying information required Any other than recommended coding should be documented. Reference to the source of mortality data should be provided. 9

4. Population life tables These files are only requested if the submitted cancer cases file contain the information on follow-up for vital status. Format Ideally, the file should contain probabilities for every combination of: Calendar year (all incidence and follow-up years) Sex Age (year unit) Alternatively, the next finest level of detail available, with a maximum of 5-year age groups and a minimum of the 85+ last age group (or higher). Survival probabilities for general (all causes) mortality should be provided to 6 decimal places or an equivalent number of significant figures. Data for each registry (distinguished by its registry code) should be recorded in a separate file or worksheet. Accompanying information required The layout and format of the file The key for any specific codes used for variables Method of smoothing if mortality probabilities are provided for 5 years periods (as opposed to single years) The source reference The reference person 10

Annex 3. References Conversion and verification: rules and software 1. Ferlay J, Burkhard C, Whelan S, Parkin DM. CHECK AND CONVERSION PROGRAMS FOR CANCER REGISTRIES (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42 Lyon, 2005 2. http://www.iacr.com.fr/, Software, IARCcrgTools ; accessed on 28 April 2010. 3. http://www.encr.com.fr/, Downloads, DEPedits ; accessed on 28 April 2010. ENCR recommendations 4. Parkin DM, Tyczynski JE, Démaret E, eds. Standards and guidelines for cancer registration in Europe. IARC Technical Publication No 40, 2003: 69 73. 5. http://www.encr.com.fr/, Downloads, Recommendations ; accessed on 28 April 2010. EUROCARE 5 6. http://www.eurocare.it/protocols/; accessed on 28 April 2010. IACR standards: 7. http://www.iacr.com.fr/, Standards ; accessed on 28 April 2010. ICD-10 8. WHO. International Statistical Classification of Diseases and Related Health Problems (10th Revision). Geneva: World Health Organisation, 1992. ICD-O-3 9. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology (3rd edition). Geneva: World Health Organisation, 2000. TNM classification 10. Sobin LH, Gospodarowicz MK, Wittekind C (Eds.) TNM Classification of Malignant Tumours, 7th Edition November 2009, Wiley-Blackwell. 11. www.uicc.org/tnm; accessed on 28 April 2010 12. http://www.wileyanduicc.com/; accessed on 28 April 2010. 11

Annex 4. ENCR data call requirements at a glance Cancer cases file Verification of inclusion criteria Validation Conversion to ICD-O-3 Removal of duplicate registrations Retaining all multiple primaries Checking mandatory and optional variables Adhering to the recommended coding Formatting Zipping and protecting Other data files Population file (minimum submission) Mortality data base Population life tables Other information Non-standard coding schemes used in any data files Reference to the source of population data Reference to the source of life tables CIN portal at IARC http://cinportal.iarc.fr/ Username Password Permissions for use of the data Deadline: 30 June 2010 12